Behavioral assessment of NIH Swiss mice acutely intoxicated with tetramethylenedisulfotetramine

Neurotoxicology and Teratology

Volumn 47, Issue , 2015, Pages 36-45

  Flannery, Brenna M ^a   Silverman, Jill L ^b,c   Bruun, Donald A ^a   Puhger, Kyle R ^b,c   McCoy, Mark R ^a   Hammock, Bruce D ^a,d   Crawley, Jacqueline N ^b,c   Lein, Pamela J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Behavioral testing; Mice; Seizures; Tetramethylenedisulfotetramine; TETS

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR; DIAZEPAM; TETRAMETHYLENEDISULFOTETRAMINE; UNCLASSIFIED DRUG; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; BRIDGED COMPOUND; CONVULSANT AGENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CLONIC SEIZURE; COGNITION; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; CONVULSION; DEATH; DEPRESSION; DISEASE DURATION; ELEVATED PLUS MAZE TEST; EPILEPTIC STATE; FEAR; FORCED SWIM TEST; INTOXICATION; LOCOMOTION; MALE; MOUSE; NEUROPSYCHOLOGY; NOCICEPTION; NONHUMAN; OPEN FIELD TEST; SEIZURE; TAIL FLICK TEST; TAIL SUSPENSION TEST; TONIC CLONIC SEIZURE; VOMITING; YOUNG ADULT; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; EXPLORATORY BEHAVIOR; INBRED MOUSE STRAIN; MAZE TEST; NEUROTOXICITY SYNDROMES; PATHOPHYSIOLOGY; RECOGNITION; TIME FACTOR; VISUAL ADAPTATION;

MUS;

ADAPTATION, OCULAR; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRIDGED COMPOUNDS; COGNITION DISORDERS; CONVULSANTS; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; GABA MODULATORS; MALE; MAZE LEARNING; MICE; MICE, INBRED STRAINS; NEUROTOXICITY SYNDROMES; RECOGNITION (PSYCHOLOGY); SEIZURES; TIME FACTORS;

EID: 84912100007     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2014.10.008     Document Type: Article

References (62)

1. Atillo A., Soderfeldt B., Kalimo H., Olsson Y., Siesjo B.K. Pathogenesis of brain lesions caused by experimental epilepsy. Light- and electron-microscopic changes in the rat hippocampus following bicuculline-induced status epilepticus. Acta Neuropathol 1983, 59:11-24.
2. Bai H., Zhang S.L., Zhang H.S., Ji J.T., Ma P.B., Wang H.S., et al. Evaluation of therapeutic project on acute tetramethylene disulphotetramine poisoning and effect on intelligence in children. Zhonghua Yu Fang Yi Xue Za Zhi 2005, 39:95-98.
3. Bailey K.R., Pavlova M.N., Rohde A.D., Hohmann J.G., Crawley J.N. Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol Biochem Behav 2007, 86:8-20.
4. Banks C., Yang D., Lein P., Rowgawski M. Tetramethylenedisulfotetramine. Encyclopedia of toxicology 2014, 509-511. Elsevier Inc. Academic Press. 3 ed. P. Wexler (Ed.).
5. Barrueto F., Furdyna P.M., Hoffman R.S., Hoffman R.J., Nelson L.S. Status epilepticus from an illegally imported Chinese rodenticide: "tetramine". J Toxicol Clin Toxicol 2003, 41:991-994.
6. Bevins R.A., Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 2006, 1:1306-1311.
7. Brielmaier J., Matteson P.G., Silverman J.L., Senerth J.M., Kelly S., Genestine M., et al. Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS ONE 2012, 7:e40914.
8. Can A., Blackwell R.A., Piantadosi S.C., Dao D.T., O'Donnell K.C., Gould T.D. Antidepressant-like responses to lithium in genetically diverse mouse strains. Genes Brain Behav 2011, 10:434-443.
9. Clapcote S.J., Lazar N.L., Bechard A.R., Roder J.C. Effects of the rd1 mutation and host strain on hippocampal learning in mice. Behav Genet 2005, 35:591-601.
10. Clapcote S.J., Lazar N.L., Bechard A.R., Wood G.A., Roder J.C. NIH Swiss and Black Swiss mice have retinal degeneration and performance deficits in cognitive tests. Comp Med 2005, 55:310-316.
11. Corona A.W., Fenn A.M., Godbout J.P. Cognitive and behavioral consequences of impaired immunoregulation in aging. J Neuroimmune Pharmacol 2012, 7:7-23.
12. Crawley J.N. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice 2007, John Wiley and Sons, New York, NY. 2nd ed.
13. Crawley J.N. Behavioral phenotyping strategies for mutant mice. Neuron 2008, 57:809-818.
14. Crawley J., Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980, 13:167-170.
15. Croddy E. Rat poison and food security in the People's Republic of China: focus on tetramethylene disulfotetramine (tetramine). Arch Toxicol 2004, 78:1-6.
16. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790.
17. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
18. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
19. Dere E., Huston J.P., De Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 2007, 31:673-704.
20. Drexel M., Preidt A.P., Sperk G. Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex. Neuropharmacology 2012, 63:806-817.
21. Eikelenboom P., Bate C., Van Gool W.A., Hoozemans J.J., Rozemuller J.M., Veerhuis R., et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002, 40:232-239.
22. Eriksson K.J., Koivikko M.J. Status epilepticus in children: aetiology, treatment, and outcome. Dev Med Child Neurol 1997, 39:652-658.
23. File S.E., Lippa A.S., Beer B., Lippa M.T. Animal tests of anxiety. Current protocols in neuroscience/editorial board, Jacqueline N Crawley [et al.] 2004, [Chapter 8: Unit 8 3].
24. Fujikawa D.G., Itabashi H.H., Wu A., Shinmei S.S. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 2000, 41:981-991.
25. Gimeno D., Kivimaki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009, 39:413-423.
26. Griffin R., Nally R., Nolan Y., McCartney Y., Linden J., Lynch M.A. The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem 2006, 99:1263-1272.
27. Guan F.Y., Liu Y.T., Luo Y., Hu X.Y., Liu F., Li Q.Y., et al. GC/MS identification of tetramine in samples from human alimentary intoxication and evaluation of artificial carbonic kidneys for the treatment of the victims. J Anal Toxicol 1993, 17:199-201.
28. Hein A.M., Stutzman D.L., Bland S.T., Barrientos R.M., Watkins L.R., Rudy J.W., et al. Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus. Neuroscience 2007, 150:754-763.
29. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 1996, 54:21-30.
30. Holmes A., Iles J.P., Mayell S.J., Rodgers R.J. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav Brain Res 2001, 122:159-167.
31. Iura Y., Udo H. Behavioral analyses of visually impaired Crx knockout mice revealed sensory compensation in exploratory activities on elevated platforms. Behav Brain Res 2014, 258:1-7.
32. Kulesskaya N., Voikar V. Assessment of mouse anxiety-like behavior in the light-dark box and open-field arena: role of equipment and procedure. Physiol Behav 2014, 133:30-38.
33. Kuo H.K., Yen C.J., Chang C.H., Kuo C.K., Chen J.H., Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005, 4:371-380.
34. Li J.M., Gan J., Zeng T.F., Sander J.W., Zhou D. Tetramethylenedisulfotetramine intoxication presenting with de novo status epilepticus: a case series. Neurotoxicology 2012, 33:207-211.
35. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92:180-185.
36. Liu C., Li Y., Lein P.J., Ford B.D. Spatiotemporal patterns of GFAP upregulation in rat brain following acute intoxication with diisopropylfluorophosphate (DFP). Curr Neurobiol 2012, 3:90-97.
37. Lu Y., Wang X., Yan Y., Xiao Z., Stephani U. Nongenetic cause of epileptic seizures in 2 otherwise healthy Chinese families: tetramine-case presentation and literature survey. Clin Neuropharmacol 2008, 31:57-61.
38. Lucki I., Dalvi A., Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 2001, 155:315-322.
39. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53.
40. McDonough J.H., Dochterman L.W., Smith C.D., Shih T.M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 1995, 16:123-132.
41. Meldrum B.S., Vigouroux R.A., Brierley J.B. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973, 29:82-87.
42. Milner L.C., Crabbe J.C. Three murine anxiety models: results from multiple inbred strain comparisons. Genes Brain Behav 2008, 7:496-505.
43. Piazza A., Lynch M.A. Neuroinflammatory changes increase the impact of stressors on neuronal function. Biochem Soc Trans 2009, 37:303-307.
44. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
45. Ramzy A. Two children die in mass poisoning at Chinese kindergarten 2014, The New York Times.
46. Shakarjian M.P., Veliskova J., Stanton P.K., Velisek L. Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABA(A) receptors. Toxicol Appl Pharmacol 2012, 265:113-121.
47. Sheppard E., Lippe S. Cognitive outcome of status epilepticus in children. Epilepsy Res Treat 2012, 2012:984124.
48. Shih T.M., Duniho S.M., McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003, 188:69-80.
49. Silverman J.L., Yang M., Turner S.M., Katz A.M., Bell D.B., Koenig J.I., et al. Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience 2010, 171:1197-1208.
50. Silverman J.L., Turner S.M., Barkan C.L., Tolu S.S., Saxena R., Hung A.Y., et al. Sociability and motor functions in Shank1 mutant mice. Brain Res 2011, 1380:120-137.
51. Smith C. Review: the long-term consequences of microglial activation following acute traumatic brain injury. Neuropathol Appl Neurobiol 2013, 39:35-44.
52. Soderfeldt B., Kalimo H., Olsson Y., Siesjo B. Histopathological changes in the rat brain during bicuculline-induced status epilepticus. Adv Neurol 1983, 34:169-175.
53. Soderfeldt B., Kalimo H., Olsson Y., Siesjo B.K. Bicuculline-induced epileptic brain injury. Transient and persistent cell changes in rat cerebral cortex in the early recovery period. Acta Neuropathol 1983, 62:87-95.
54. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
55. Steward O. Electroconvulsive seizures upregulate astroglial gene expression selectively in the dentate gyrus. Brain Res Mol Brain Res 1994, 25:217-224.
56. Trinka E., Hofler J., Zerbs A. Causes of status epilepticus. Epilepsia 2012, 53(Suppl. 4):127-138.
57. Vito S.T., Austin A.T., Banks C.N., Inceoglu B., Bruun D.A., Zolkowska D., et al. Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication. Toxicol Appl Pharmacol 2014, (in press). 10.1016/j.taap.2014.10.001.
58. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007, 2:322-328.
59. Whitlow K.S., Belson M., Barrueto F., Nelson L., Henderson A.K. Tetramethylenedisulfotetramine: old agent and new terror. Ann Emerg Med 2005, 45:609-613.
60. Yang M., Bozdagi O., Scattoni M.L., Wohr M., Roullet F.I., Katz A.M., et al. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci 2012, 32:6525-6541.
61. Zhang Y., Su M., Tian D.P. Tetramine poisoning: a case report and review of the literature. Forensic Sci Int 2011, 204:e24-e27.
62. Zolkowska D., Banks C.N., Dhir A., Inceoglu B., Sanborn J.R., McCoy M.R., et al. Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J Pharmacol Exp Ther 2012, 341:435-446.